PM647

N/A

Report date: 2025/12/17 17:47:42

Base Information

Drug NamePM647

Drug Alias NamePM-647

ClassificationCell and gene therapy > Gene therapy > LNP

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPrime Medicine Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active Indicationsalpha 1-Antitrypsin Deficiency

Inactive IndicationsN/A

ATC CodeN/A